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Abstract Staphylococcal toxins, leukocidin and y-hemolysin, 
consist of two protein components, i.e. LukF and LukS for leu- 
kocodin and HyI and H~/II for "},-hemolysin. From a culture fluid 
of Staphylococcus aureus strain P83, a new protein component 
of leukocidin or 3,-hemolysin which was designated as LukM was 
isolated. This component showed the same biological activity as 
that of LukF component for leukocidin or HyI component of 
y-hemolysin in combination with LukS or HyII. However, the 
LukM component cross-reacted with the anti-LukS antibodies 
but not with the anti-LukF antibodies. On the basis of chemical 
analysis of the LukM component and the cloning and nucleotide 
sequencing of the l ukM gene of S. aureus P83, we have demon- 
strated that LukM is an entirely new protein component of leu- 
kocidin or y-hemolysin. The deduced amino acid sequence of 
LukM from the lukM gene showed 66.7% and 67% indentity to 
that of LukS and HyII, respectively. However, the amino acid 
sequence of LukM and LukF showed only 29% homology. 
S. aureus P83 is available, because their results came from the 
study only on the recombinant LukF and LukS in Escherichia 
coli. 
The gross dissimilarity of the activity between leukocidin and 
leukocidin R raises the question whether or not there is any 
relationship between them. To answer this question, we started 
to obtain homogeneous preparations of the native LukF and 
LukS from S. aureus P83. While purifying the LukF and LukS 
from a culture fluid of S. aureus P83, we accidentally isolated 
a new protein component which was designated LukM compo- 
nent. In this study, by the chemical and biological analyses of 
the LukM and the identification of its gene from S. aureus P83, 
we demonstrate that the LukM is an entirely new protein com- 
ponent, having the same activity as LukF. 
2. Materials and methods 
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1. Introduction 
Staphylococcal toxins, leukocidin and ),-hemolysin, consist 
of two protein components, i.e. LukF and LukS for leukocidin 
and H?'I and H?'II for ?,-hemolysin. By the chemical and immu- 
nological analyses of the four components and the cloning and 
nucleotide sequencing of the genes, we demonstrated that 
leukocidin and ?,-hemolysin share LukF or H?,I component in 
the two toxins, and the specificity of both toxins depends on 
the LukS and H?'II component [1-3]. Supersac et al. also re- 
ported the nucleotide sequence of lukR gene for leukocidin, 
known as leukocidin R of Staphylococcus aureus P83 [4]. The 
deduced amino acid sequences of their recombinant LukF 
(LukF-R) and LukS (LukS-R) components are not identical 
but very close to that of our LukF and LukS, respectively [4]. 
Unlike our LukS and LukF, LukF-R in combination with 
LukS-R induced hemolysis of human erythrocytes as well as 
leukocytotoxic activity on human polynuclear leukocytes [4]. 
However, no information about intact LukF and LukS from 
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2.1. Isolation and purification of LukM component 
S. aureus P83 (ATCC 31890) was grown in 2.5% heart infusion broth 
(Difco) at 37°C for 24 h under aeration with OJCO2 (80 : 20, v/v) and 
the culture supernatant was collected by centrifugation at 4°C. The 
leukocidin and 7z-hemolysin components were purified according to the 
methods described previously [1]. Four protein peaks, designated I, II, 
III, and IV in order of elution, were obtained (Fig. 1). Components I, 
III, and IV were eluted at the positions where LukF, LukS, and HTzII 
were usually eluted, respectively. In contrast, component II, which was 
designated as LukM, was eluted at a new position. These were separe- 
rely purified by rechromatograpy on the SP-5PW column (Tosoh, 
Tokyo), dialyzed against 30 mM sodium phosphate buffer, pH 6.5 and 
stored at -80°C until used. As will be described below, components I, 
III, and IV were identified as LukF, LukS, and HTzII, respectively. 
2.2. Assay of leukocidin and 7z-hemolysin activities 
Leukocidin activity was determined by the method escribed previ- 
ously [1]. For the determination f the y-hemolysin activity, the LukF 
or LukM component (4pmol) was incubated with the human red blood 
cells (1.5 x 108) in 300/11 of saline containing 20 mM sodium phosphate 
buffer (pH 6.8) at 34°C for 1 min. Then the HTZlI component (4 pmol) 
was added to the reaction mixture and incubated for 15 min at 34°C. 
After the reaction mixture was centrifuged at 7,000 × g for 5 min, a 
supernatant was collected. The absorbance of the supernatant was 
measured at 541 nm. 
2.3. N-terminal amino acid sequence of the intact LukM component and 
its peptide fragments by cyanogen bromide cleavage 
The purified LukM component was cleaved by CNBr according to 
the method described by Matsudaira [5]. The LukM (100 ,ug) was 
dissolved in 1 ml of 70% formic acid containing 200/2g of CNBr, and 
was kept in the dark under argon gas at 24°C for 24 h. After lyophili- 
zation, the sample was applied to the SDS-PAGE using 15% gel. The 
CNBr-fragments were blotted on the PVDF membrane. After being 
staining with Ponceau S, CNBr-fragments on the membrane were di- 
rectly analyzed for an N-terminal amino acid sequence. Intact I, III, 
and IV components were also analyzed for N-terminal amino acid 
sequences. The N-terminal sequence was determined by the method 
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described previously [6] using a gas phase protein sequencer (model 
PSQ-1, Shimadzu, Kyoto) equipped with an on line amino acid analyzer 
(model RF-550, Shimadzu, Kyoto). 
2.4. Amplification of a part of the LukM gene by PCR 
The purified chromosomal DNA from S. aureus P83 was used as a 
template. According to the N-terminal amino acid sequence of intact 
LukM and its CNBr-fragments, oligonucleotide primers were synthe- 
sized. The PCR amplification was performed 35 cycles with Taq polym- 
erase (Takara shuzo, Kyoto) using the following temperature profile, 
94°C, 1 min; 55°C, 2 min; 72°C, 2 min. The amplified products were 
purified by agarose lectrophoresis. After phosphorylation, the DNA 
fragment was inserted into SmaI site ofpUC119 vector DNA, then was 
fransformed into E. coli DH5c~. 
2.5. Genomic loning of the lukM from the chromosomal DNA of 
S. aureus P83 
The purified chromosomal DNA from S. aureus P83 was double- 
digested with HindlII and EcoRI, and was applied to agarose gel elec- 
trophoresis. After southern blotting, the DNA was hybridized with the 
32p-labeled 500 bp-DNA fragment which was a part of the DNA of 
lukM obtained by PCR. About 4 kbp-fragments were hybridized. Ac- 
cordingly, the fragments were extracted from the gel, and were inserted 
into the EcoRI-HindlII site of pUC118 plasmid vector DNA. After 
transformation f the recombinant DNA into E. coli DHfc~, the recom- 
binant containing the lukM gene was obtained by colony hybridization 
with the 32P-labeled 500 bp-fragment. 
2.6. Other analytical procedures 
SDS-PAGE and Western immunoblot analyses were done by the 
methods described previously [1]. The amino acid analysis was per- 
formed by the method described previosuly [I]. 
The nucleotide sequence was determined by the methods described 
previously [2]. 
3. Results and discussion 
3.1. Isolation o f  the LukM component 
Attempting to purify LukF, LukS, and H?'II from the culture 
fluid of S. aureus P83, we noticed that a new protein peak, 
designated as LukM was eluted from the HPLC column at the 
position between LukF and LukS (Fig. 1A). We therefore puri- 
fied the protein as well as the LukF, LukS, and H~,II compo- 
nents to gel electrophoretic homogeneity (Fig. 1B). Identity of 
the components I, III, and IV with LukF, LukS, and HTII, 
respectively, was confirmed by sequencing the N-terminal 40- 
residues (data not shown). 
3.2. Leukocidin and y-hemolysin activities o f  LukM in 
combination with LukS  and Hy l I  
A synergistic action of LukM and LukS caused leukotoxic 
activity. The concentration of LukM as well as LukF required 
for 100% leukocytolytic activity toward l0  6 human polymor- 
phonuclear leukocytes in 10 min in the presence of LukS 
(1/,tg/ml) was determined to be 1/~g/ml. Furthermore, LukM 
showed a ~'-hemolysin activity in combination with Hy l I  (Fig. 
2, wells 1 and 5). Although the reason why the hemolysin 
activity of  LukM was about 1/5 of that of LukF, in the presence 
of Hy l I  is still to be elucidated, this finding indicates that 
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Fig. 1. Elution profile of leukocidin and ?'-hemolysin components from the SP-fPW cation exchange column and SDS-PAGE analysis of the purified 
LukF, LukM, LukS, and HylI components. (A) Leukocidin and ?'-hemolysin fractions eluted from a hydroxylapatite column were subjected to HPLC 
(TOSOH, Tokyo) epuipped with a TSK gel SP-5PW column. -- ,  Absorbance at 280 nm;- --, NaCI concentration. (B) The gel was stained with 
Coomassie brilliant blue R-250. Molecular mass standards used were phosphorylase b (97.4 kDa), bovine serum albumin (66.2 kDa), ovalbumin (45 
kDa), bovine carbonic anhydrase (31 kDa) and soybean trypsin inhibitor (21.5 kDa). 
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Fig. 2. y-Hemolysin synergism on human blood agarose plate. 1, LukF 
+ HyII; 2, LukF; 3, HyII; 4, LukM; 5, LukM + H),II. The concentra- 
tion of each component was adjusted to 100 ng/pl in PBS (pH 7.2). The 
amount of each component applied to the well was 120 ng. The plate 
was incubated at 37°C for 14 h. 
the LukM component has the same physiological property 
as that of the LukF component. No phospholipase A and 
(/4) 
intact LukM 
C activity was detected in the LukM preparation (data not 
shown). 
3.3. Characterization of the LukM component 
The molecular mass of LukM (32 kDa) was smaller than that 
of LukF (34 kDa). Although physiological property of LukM 
was the same as LukF, LukM was positive to anti-LukS anti- 
body, whereas this cross-reacted neither anti-LukF nor anti- 
HyII  antibodies. Furthermore, the N-terminal 47-residue se- 
quence of LukM determined in this study was 70% identical 
with that of LukS [4,7] but only 17% homology was found 
between those of LukM and LukF [4,8]. The isoelectric point 
of LukM was determined to be 9.4 by the method described 
previously [8]. 
3.4. Molecular cloning and nucleotide sequence of the luk M from 
S. aureus P83 
According to the N-terminal amino acid sequence of intact 
LukM and its CNBr-fragments, C (17 kDa) and D (5 kDa), the 
oligo-nucleotides primers were synthesized (Fig. 3). In combi- 
nation with primers I and III, about 250 bp-fragment was 
amplified from the chromosomal DNA of S. aureus P83 by 
PCR. Also, in combination with primers II and IV, a DNA 
fragment with about 500 bp was amplified. By DNA sequence 
of the two fragments, it was confirmed that the 250 bp- and 500 
bp-fragments had a DNA sequences corresponding to the 
amino acid sequence of determined N-terminal 47-residue of 
Fragment 
~A 
~B 
~C 
~D 
(B) 
1o 
Intact LukM I:T T N A E D I G D D k E V I 
Pr i mer I 5' -GAA6ACATCG6TGACGACGCAGAA61"-3' 
T T C T T T 
K R 
20 
T E D V S S 
30 
R K W G V T Q N 
40 
31:V O F D F V K D K K Y N K D A L I 
Fragment C I:V W P F Q Y N I G L T S K D Q N T S 
Pr imer II 5' -GGTCTrACTTC~CCAGAAAAC-3" 
A T A T A T 
Primer II 3' -CCAGAATGTAGATI-rCTAGI-F1TATG-5' 
A T C G C T 
L I N Y L P K N K I E T 
Fragment D I:D V T Y A T Y L P K L G L Y P E R K H N 
Primer IV 3'-CTGCAAT6GATAC66TGGAT66A-5' 
A G T T A 
Fig. 3. SDS-PAGE analysis of the peptide fragments by CNBr cleavage of the purified LukM component (A) and the N-terminal mino acid sequences 
of the intact LukM component and its CNBr-fragments, C and D (B). The oligonucleotide primers, I II, III, and IV expected from the N-terminal 
amino acid sequence of the intact LukM, the fragments C and D are also shown in this figure. 
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10 20 30 40 50 6~ 
GATCGTGTTTGAATGTTTTTTGGGTGTAACAATACTATTTTAGAGATTTATTAACCTTA~ 
70 80 90 100 110 120 
TG-- -~TTT~T~ATTTTTAATTA~ATGAATTATGTAATAGTATAAATTTGTA 
130 140 150 180 170 180 
TTAAAAATAT~AGAG~AGA~GTGAAACTATGTTT~TAGA/L%ATTATTAGTTAC~C 
M F N R K L L V T T  
190 200 210 220 230 240 
TTTGTCGCTAGGTCTAATTGTCCCTATAGCTACACCATTTCAAGGCTCT~GGCTACTAC 
L S L G L I V P I A T P F Q G S K A T T  
250 280 270 280 290 300 
TAATGCAG~GATATTGGCGACGATGCAG~GTGATTAAACGTACGG~GATGT~GTAG 
. _ _ . _ , _ . __ , _ . _ , _ , _ . _ . _ . _ , _ , - . - ' - ' - ' - ' - - ' - ' -  
310 320 330 340 350 380 
TAGG~ATGGGGTGT~CAC~AATGTCCAATTTGATTTCGTAAAAGAT~TATAA 
__._._.__.___.__,__.__.__.__.__.--.-.-.-.-.-,-.-.-,- 
370 380 390 400 410 420 
CA~GACGCATT~TTATT~GATGCAAGGT~TATC~TTCTAGGAC~CTTTCAATGA 
_ K _ D ~ _ ~ _ _ L I K M Q G F I N S R T T F N D  
430 440 450 480 470 480 
TGTTAAACA~TAGAGCAAATAAAAG~TGGTTTGGCCATTTC~TATAATATCGGTCT 
VKQNRANKRMV_W__~_~_~_~_~__~_~_~_ 
490 500 510 520 530 540 
TACATCAAAAGACCAAAATACGAGCTTAATC~TTATCTTCCTAAAAATAAAATAG~AC 
_ . _ , _ . __ . _ , _ . __ . _ . _ . __ . _ , _ . _  _~_g_ ~_3L_~_L_  ~_3_ 
550 580 570 580 590 800 
AGTTGATGTTGGTC~ACTTTAGGATAT~CATTGGAGGTAAATTCCAGTCAGTACCATC 
V D V G Q T L G Y N I G G K F Q S V P S  
810 820 830 840 850 880 
TATAGGCGGA~TGGATCATTT~TTA~CT~GAGTATT~ATATTCCC~GAGTTA 
I G G N G S F N Y S K S I K Y S Q K S Y  
670 680 890 700 710 720 
TGTCAGCG~GTTG~C~CAAAGCTC~ACTATT~GTGGGGGGTTA~GC~ATTC 
V S E V E Q Q S S K T I K W G V K A N S 
730 740 750 760 770 780 
TTTTGTTATAGCAGGGCATCGATGGTCTGCTTACGATGAATTATTGTTTAT~GAAATAC 
F V I A G H R W S A Y D E L L F I R N T  
790 800 810 820 830 840 
GAC~GAGGACCT~TGCTAGAGACTATTTTGTAGACGAT~TGAATTGCCCCCTTT~T 
T R G P N A R D Y F V D D N E L P P L I  
850 880 870 880 890 900 
AACAAGTGGATTT~TCCGTCTTTTATCGCGACAGTATCTCACGAAA~GATTCAGGCGA 
T S G F N P S F I A T V S H E K D S G D  
910 920 930 940 950 960 
TACGAGCGAATTTGAAATTACTTACGGTAGAAATATGGATGTTACCTATGCAACCTACCT 
T S e F E I T Y G R N M E_  ~- ! - -X -  ~- [ -~- -~-  
970 980" 990 1000 1016 1020 
CCCT~ACTTGGTCTTTATCCAGAAAG~AACATAATG~TTTGTAAACAG~ACTTGGT 
_ , _ . _ . _ . __ . _ . _ . _ , _ . _ . _ , __ , _  E F v N R ~ L V 
1030 1040 1050 1080 1070 1080 
GGTC~ATATGAAGTG~TTGGAAAACGTCCGAACTT~GGT~GGGGGCACAACTAATT 
V K Y E V N W K T S E L K V R G H N -  
1090 1100 1110 1120 1130 1140 
TGAATTTAGGGATTATGGTC~TTCATCAGTCGCTACATCAATTACATTACTCATGCTTA 
i150 1180 I170 
TCACTCCAGTGGGTGCAGCTCACATTTCACCTGCCA 
Fig. 4. Nucleotide sequence containing the ~kM gene ~om ~ aureus 
P83 and the deduced amino acid sequence. The strand shown is ~om 
the 5' to 3' direction. Amino acid sequences analyzed chemically, puta- 
tive ribosomal binding sites, signal peptide sequence, promoter se- 
quence are indicated by broken lines, double underlines, ingle under- 
lines, and boxes, respectively. 
intact LukM and N-terminal 30-residue of the fragment C, 
respectively. Therefore, we used the 500 bp-fragment as a probe 
for the genomic loning of the lukM gene from S. aureus P83. 
The 4.0 kbp HindII I-EcoRI-fragment of the chromosomal 
DNA from S. aureus P83 was strongly hybridized (data not 
shown). Accordingly, we cloned this fragment into the EeoRI -  
HindIII site of plasmid pUCII8 vector DNA and transformed 
into E. coli DH5a. This plasmid was designated as pMWK1. 
About 2.2 kbp Sau3A-Sau3A-fragment in this plasmid con- 
tained the lukM gene (data not shown). Therfore, we have 
determined the nucleotide sequence of the fragment containing 
the lukM and its 5'-and Y-flanking regions. The determined 
nucleotide sequence of the fragment was comprising 1,176 bp 
as shown in Fig. 4. Within this sequence, we can identify an 
open reading frame which begins with ATG codon at position 
152 and terminates with TAA at position 1,076. The open 
reading frame encoded protein of 309 amino acids with a calcu- 
lated molecular mass of 35,006. The N-terminal 47, 30, and 20 
amino acid residues of the intact LukM and its CNBr-frag- 
ments, C and D were identical to the deduced 47 amino acid 
residues from 29th N-terminal amino acid residues to 75th one, 
from 101th to 130th, and from 263th to 282th, respectively (Fig. 
4). 
On the basis of the N-terminal amino acid sequence of the 
secreted LukM component (Fig. 4), the position of Ala 2s - Thr 29 
of the pre-matured LukM component might be processed by 
signal peptidase to secrete as a matured protein. No cystein 
residue was detected from the deduced amino acid sequence of 
LukM and chemical analysis of secreted LukM (data not 
shown). The total amino acid composition of matured LukM 
deduced from the nucleotide sequence (from bases 236 to 1,075) 
almost corresponded with that the purified LukM (data not 
shown). 
3.5. Amino acid homology study 
Comparison of the peptide sequence (Fig. 5) of matured 
LukM with that of the LukS, LukF, and HTII from S. aureus 
RIMD 310925 [2] evidenced 66.7%, 29.0% and 67.0% homology 
in the entire amino acid sequence. 
3.6. The nucleotide sequence of  5"- and Y-flanking regions 
The following observations were made concerning the DNA 
sequence of 5'- flanking region of lukM. (i) Typical Shine 
Dalgarno sequence (GAAAG) [9] at both 16 base pair and 11 
base pair upstream from the initiation codon for LukM compo- 
nent were found. (ii) The sequence TATAAT at -61 to -66 bp 
from the translation i itiation codon of the gene assumed to be 
-10, shared the homology of the bases of the E. coli sequence 
with a conserved initial TA and the final T as Pribnow box [10]. 
Another sequence TTGAAT at positions -87 to -92 bp from 
the initiation codon and 21 bp from the -10 sequence was 
presumed to be a -35 promoter sequence. A typical transcrip- 
tion termination codon was not found between the stop codon 
of the lukM gene and the last codon sequenced. 
From the results reported here, it was demonstrated that the 
LukM component is a new component which has chemical and 
immunological properties imilar to that of the LukS compo- 
nent ofleukocidin and has physiological properties same as that 
of the LukF of the two-component toxin, leukocidin or y- 
hemolysin. Our sequence data will be helpful for the detail 
study of the role of the LukM protein in the toxic mechanism 
of leukocidin and y-hemolysin. 
3.7. Distribution of  the lukM gene among various S. aureus 
strains 
So far the distribution of the lukM gene among S. aureus P83, 
RIMD 310925, 5R Smith, and CN 4696 have been investigated 
by Southern blot hybridization and PCR, only P83 strain which 
was used in this study possesed the lukM (data not shown). 
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LukM 1 : TTNAEDIG-D-DAEVIKRTEDVSSfhKWGVTQNVQFDFVKDKKYNKDALI IK~GFINSRT 
LukS 1 : ANDTEDIGKGSDIEI IKRTEDKTSNKWGVTQNIQFDFVKDTK~ILKMQGFISSRT 
HyII 1 : ENK I ED I GQC, A- - E I I KIRTQD I TSKRLA I TQN I QFDFVKDKKYNKDALVVKMQGF I SSRT 
#Ioo  • #### • ~ ~oQ oeo Joo# ~4~o~Q~J  o~oo~# Q~# 
61 : TFNDVKQNRANK~FQYNIGLTSKDQNTSLINYLPKNKIETVDVC,  QTLGYNIC, GKFQ 
61 : ~FQYNIGLKTNDKYVSL INYL~IESTNVSQTLGYNIGGNFQ 
81 : TYSDLKKYPYIKRMIWPFQYNISLKTKDSNVDLINYLPK IDSADVSO~IGGNFQ 
w e • • eoeeee4D • • oeeeeeeeeo 4~ 4~ 4 Jeeew4J4~ 4~4~ 
121 : SVPSIGGNGSFNYSKSIKYSOKSYVSEVE~SKTIKWGVKANSFVIAGHRWSAYDELLF 
1Z 1 : SAPSLGGNGSFNYSKS I SYTQ~SEVE~SKSVLWGVI (ANSFATESC~AFDSDLF  
121 : SAPS I GGSGSFNYSKTI SYNQKNYVTEVESQNSKGVKW~SFVTPNGQVSAYDQYLF  
t t~  o~ ##oJw~ • # # ~ or# # J# #~o###~o ~# • #o 
181 : I IRN'rrHGPN~DYFVDDNELPPLITSGFNPSFIATVSHEKDSGDTSEFEITYGRNM~ 
181 :~GYKPHSKDY~DYFVPDSELPPLVQSGFNPSF IATVSHEKGSSDTSEFE ITY~ 
181 :~O- DPTGPA~DYFVPDNQLPPL IQSGFNPSF I TTLS~GKGDKSEFE I  T Y ~  
eewoe • ew~e eeweweme • eew • eoeoowoeooow • 
241 : .~-'~.I:~-~-L¥- - P ~ ~ S F . , L ~ ( ~ ' ~  - -  
241 : A I ~ ' ~ - Z Y ~ T ~ - ~ R ~ I ~ . ~ - -  
241 : AY- -VTR--HR-LAVE~KHD IKSITPK 
Fig. 5. Comparison of the deduced amino acid sequence of LukM component with that of LukS and HZII. The sequences were compared using the 
GCG program GAP uning weight of 4. Identical residues are indicated by stars. The gross differences between them are indicated by boxes. 
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